Efavirenz + Emtricitabine + TDF 600/200/300 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 600/200/300 mg
Reference Brands: Atripla(US/EU)
Category: Anti Viral
Efavirenz 600 mg, emtricitabine 200 mg and tenofovir DF 300 mg tablets, a complete once-daily single-tablet HIV regimen. For national HIV programmes, donor-funded tenders, hospitals and licensed importers.
Manufacture or export Efavirenz + Emtricitabine + TDF? List it or send an offer →
Product Description:
This single tablet holds a complete once-daily HIV regimen: efavirenz 600 mg, a non-nucleoside reverse transcriptase inhibitor, with emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg, two nucleoside or nucleotide reverse transcriptase inhibitors. The three drugs act on the same viral enzyme at two different sites, making resistance harder to develop. A close relative uses lamivudine in place of emtricitabine; they are not the same product, and tenders specify which they want.
WHO guidelines now prefer dolutegravir-based first-line treatment, with efavirenz kept as an alternative, often at 400 mg, so demand for this 600 mg form has fallen. It is taken once daily on an empty stomach, ideally at bedtime, to ease efavirenz's dizziness, vivid dreams and mood changes. A psychiatric history needs care. Tenofovir DF can harm kidney function and bone density, so creatinine is checked. Efavirenz induces liver enzymes, lowering levels of many drugs including some hormonal contraceptives. Stopping it in hepatitis B co-infection can trigger a flare.
Sourcing notes. Donor-funded and public tenders usually want WHO prequalification or stringent-authority approval; ask for the reference and check that it is current. Confirm patent and licensing status in the destination before quoting. Request a CoA per batch with assay, dissolution and related substances for all three actives, the bioequivalence report, the GMP certificate and a CoPP. The large film-coated tablets are moisture-sensitive and usually packed 30 to an HDPE bottle with desiccant. Zone IVb stability data matter for hot humid markets. State bottle count, quantity and label language.
Efavirenz + Emtricitabine + TDF — third party manufacturing & bulk supply
Efavirenz + Emtricitabine + TDF 600/200/300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Efavirenz + Emtricitabine + TDF is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Efavirenz + Emtricitabine + TDF listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Efavirenz + Emtricitabine + TDF →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (TDF) are used together as a single-tablet regimen to treat HIV-1 infection. This combination helps lower viral load, improve immune function, and prevent HIV progression when taken regularly.
It is made from three antiretroviral agents: efavirenz (a non-nucleoside reverse transcriptase inhibitor), emtricitabine (an NRTI), and tenofovir disoproxil fumarate (an NRTI). Together they block HIV replication at multiple stages.
The common trade name is Atripla.
Atripla is co-developed by Gilead Sciences and Bristol-Myers Squibb, with several generic manufacturers producing it globally.
The generic name is efavirenz, emtricitabine, and tenofovir disoproxil fumarate.
The primary brand name is Atripla.
It is manufactured in approved facilities in the USA, Europe, and India, depending on whether it is the innovator or a generic version.
Related Products
Efavirenz
Strength:
Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg
Form: Tablet & Capsule
Reference Brands: Sustiva®(US); Stocrin®(EU)
View DetailsLamivudine & Zidovudine
Strength:
Lamivudine 150 mg + Zidovudine 300 mg
Form: Tablet
Reference Brands: Combivir®(US/ EU)
View DetailsAtazanavir & Ritonavir
Strength:
300 mg Atazanavir + 100 mg Ritonavir
Form: Tablets
Reference Brands: Evotaz®(US)
View DetailsAbacavir Sulphate
Strength:
Tab: 300 mg; oral solution: 20 mg/ml
Form: Tablet and Oral Solution
Reference Brands: Ziagen® (EU & US)
View DetailsValganciclovir
Strength:
Tab: 450 mg; Oral solution: 50 mg/mL
Form: Tablet & Oral solution
Reference Brands: Valcyte®
View DetailsNelfinavir Mesylate
Strength:
Tablets: 250 mg, 625 mg: Oral Powder: 50 mg/g
Form: Tablet & Oral Powder
Reference Brands: Viracept®
View DetailsRitonavir & Lopinavir
Strength:
Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL
Form: Tablet and Oral Solution
Reference Brands: Kaletra(US & EU)
View DetailsSofosbuvir / Ledipasvir
Strength:
Sofosbuvir 400 mg & Ledipasvir 90 mg
Form: Tablet
Reference Brands: Harvoni®(EU & US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit